SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the third quarter of fiscal year 2022 after the stock market closes on Tuesday, Aug. 16. The company will host a live webcast of its investor conference call in listen-only mode on the same day. Details for the webcast: … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostics (IVD) in India” report has been added to ResearchAndMarkets.com’s offering. This new report is designed to provide an overview of the IVD market in India and its influences. Included in the report are trends influencing the industry and country-level data including the incidence of disease, life expectancy, population demographics, economic … [Read more…]
Partnership will offer easy-to-use app and personalized cough frequency information to consumers including the estimated 12 million adults in the U.S. who suffer from chronic cough1 NEW YORK–(BUSINESS WIRE)–Hyfe, Inc., the global leader in AI-powered cough detection, tracking and classification, has entered into an agreement with Merck, known as MSD outside the United States and … [Read more…]
Healthcare Cloud Services Provider Adds Seasoned Executive to Board of Directors to Assist with Driving Growth and Market Expansion MARLBOROUGH, Mass.–(BUSINESS WIRE)–CloudWave, the largest independent cloud and managed services software hosting provider in healthcare, is pleased to announce the appointment of Derek Pickell to its Board of Directors. Derek Pickell is currently Chief Executive Officer … [Read more…]
With $57M in initial financing, Cartography is creating immunotherapies that are more precise and more effective Cartography is combining cutting-edge computational and experimental techniques to profile antigens on normal and cancerous cells, creating a transformative roadmap by classifying cancers by antigen expression rather than tissue type or genetic mutation Founding team includes leaders of top … [Read more…]
ROCKVILLE, Md.–(BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), is pleased to announce its upcoming presentation of “Autopsy-Confirmed Minimally Invasive Biomarker Identifies Alzheimer’s Disease even in the Presence of Co-Morbid Pathologies” at the Alzheimer’s Association International Conference (AAIC), July 31 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “21st Edition Consumer Report, 2021 Health & Wellness Trends in America” report has been added to ResearchAndMarkets.com’s offering. The publisher is pleased to present its 2021 Health and Wellness in America, Consumer Insights and Trends Report. This report, now in its 21st year, provides insights into how today’s consumer is confronting their own … [Read more…]
— New Agreement Continues to Enable Rapid and Equitable Access to Veklury for COVID-19 Patients in EU and EEA Countries — FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences and the European Commission today signed a new joint procurement agreement (JPA) that will ensure continued rapid and equitable access to Veklury® (remdesivir) for participating Member States across the … [Read more…]
DURHAM, N.C.–(BUSINESS WIRE)–After a 14-year partnership at Duke University, Family Connects International (FCI) has launched as an independent nonprofit. The transition from a home nurse-visiting pilot initiative to a nonprofit enables it to expand services to reach more families with newborns and to provide a higher level of support to community partners across the U.S. … [Read more…]
Phase 3 clinical trial data in patients post-bunionectomy demonstrated SEGLENTIS as an efficacious and well-tolerated multimodal treatment option for appropriate adult patients with acute pain. MONTGOMERY, Ala.–(BUSINESS WIRE)–Kowa Pharmaceuticals America, Inc. announced the publication of Phase 3 clinical trial results in Pain Practice reinforcing that SEGLENTIS® a unique co-crystal combination of celecoxib 56-mg and tramadol … [Read more…]
